Search | IOVS | ARVO Journals

View

Showing 1 – 11 of 11

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2022

Efficacy and Safety of OPT-302 in combination with Ranibizumab for Polypoidal Choroidal Vasculopathy

Jason S Slakter; Hanna R. Coleman; Charles Clifton Wykoff; Clare Price; Megan E. Baldwin; Timothy L Jackson

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):382 – F0213. doi:

ARVO Annual Meeting Abstract July 2019

Identification of Novel Biomarkers in Diabetic Macular Edema (DME) and How They Change in a Streptozotocin-Induced Rat Model of Diabetic Retinal Edema

Gianna C Teague; Tytteli Turunen; Alexander Hua; Namrata Nandakumar; Francisco López; Megan Baldwin; Kameran Lashkari

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):2631. doi:

ARVO Annual Meeting Abstract July 2019

VEGF-C and VEGF-D Inhibition by VGX-300 Effectively Reduces Leukocyte Adhesion and Vascular Leakage in the STZ- Rat Model of Diabetic Retinal Edema

Tytteli Turunen; Alexander Hua; Marie Shatos; Gianna C Teague; Megan Baldwin; Kameran Lashkari

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):3667. doi:

ARVO Annual Meeting Abstract June 2017

Linear Discriminate Analysis for Design of High-Value Biomarkers in Proliferative Diabetic Retinopathy

Alexander Hua; Walter Johnson; Namrata Nandakumar; Gianna C Teague; Megan E Baldwin; Kameran Lashkari

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):2511. doi:

ARVO Annual Meeting Abstract June 2017

Plasma Levels of VEGF-C and Soluble VEGF Receptor-3 are Elevated in Neovascular AMD

Gianna C Teague; Walter Johnson; Marie Shatos; Megan E Baldwin; Kameran Lashkari

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):2327. doi:

ARVO Annual Meeting Abstract September 2016

Specific Inhibition of Inflammatory Corneal Lymphangiogenesis by Topical Inhibition of VEGF-C and -D

Felix Bock; Ann-Charlott Schneider; Megan Baldwin; Claus Cursiefen

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):3537. doi:

ARVO Annual Meeting Abstract September 2016

Expression of VEGF-A, VEGF-C, VEGF-D and soluble receptors in Clinical Age-Related Macular Degeneration

Gianna C Teague; Jie Ma; Walter Johnson; Megan E Baldwin; Kameran Lashkari

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):3698. doi:

ARVO Annual Meeting Abstract June 2015

VGX-300, a ‘Trap’ for VEGF-C and VEGF-D, Inhibits Choroidal Neovascularization and Vascular Leakage in a Mouse Model of Wet AMD

Kameran Lashkari; Jie Ma; Yu Sun; Gianna C Teague; Megan E Baldwin

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):4802. doi:

ARVO Annual Meeting Abstract June 2015

Novel Biomarkers Equations Based on Assigning Cytokines from Healthy and Disease States as Vectors in Multi-dimensional Phase Space

Namrata Nandakumar; Walter Johnson; Gianna C Teague; Jie Ma; Megan E Baldwin; Kameran Lashkari

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):5195. doi:

ARVO Annual Meeting Abstract April 2014

VEGF-C and VEGF-D Blockade by VGX-300 Inhibits Choroidal Neovascularization and Leakage in a Mouse Model of wet AMD

Kameran Lashkari; Jie Ma; Gianna C Teague; Chenying Guo; Megan E Baldwin

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):1823. doi:

ARVO Annual Meeting Abstract April 2014

Development of Biomarker Equations based on Multi-Dimensional Modeling of Cytokine Shifts in Retinal Diseases

Gianna C Teague; Namrata Nandakumar; Jie Ma; Kyle V Marra; Jorge G Arroyo; Megan E Baldwin; Walter Johnson; Kameran Lashkari

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):1919. doi:

Advertisement